Articles Referencing PRAC

Merck to Stop Selling Tredaptive - Analyst Blog

1/14/2013, 6:46 pm from Zacks.com in Investing, Business, Stocks

Merck ( MRK ) recently announced that it is taking its cholesterol management drug, Tredaptive (extended-release niacin/laropiprant), off the market. While Tredaptive (also known as Pelzont... Read >>

Merck's Tredaptive Fails in Study - Analyst Blog

12/26/2012, 11:20 am from Zacks.com in Investing, Business, Stocks

Merck ( MRK ) recently announced disappointing results from a long-term safety study of cholesterol management drug, Tredaptive (extended-release niacin/laropiprant). The company said that... Read >>